Pretty Guardian Sailor Moon -Shining Theater Shinagawa Tokyo- Phase 2 Schedule & Ticket Information Revealed!

Pretty Guardian Sailor Moon -Shining Theater Shinagawa Tokyo- Phase 2 Schedule & Ticket Information Revealed!

TOKYO, June 30, 2026 /PRNewswire/ -- "Pretty Guardian Sailor Moon -Shining Theater Shinagawa Tokyo-", a dedicated theater for Pretty Guardian Sailor Moon currently running performances at Club eX within the Shinagawa Prince Hotel, Tokyo. "Pretty...

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural history expected worsening of cUHDRS in symptomatic patients of -0.73 points over nine months, based...

Cityplaza's "Live the Game!" Extravaganza: Phase 2

Cityplaza's "Live the Game!" Extravaganza: Phase 2

HONG KONG, June 25, 2025 /PRNewswire/ -- This summer, Cityplaza and NBA Hong Kong made a vibrant slam dunk with their incredibly successful Phase 1 of the "Live the Game!" celebration for the 2025 NBA Finals. Now, get ready for a whole new wave of...

Neurizon Files IND Application to Support HEALEY ALS Platform Trial

Neurizon Files IND Application to Support HEALEY ALS Platform Trial

Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001 The IND is a comprehensive dossier of information, including animal and human studies,...

menu
menu